[
  {
    "ts": null,
    "headline": "Jim Cramer on Abbott: “I Think It’s a Terrific Time to Do Some Buying”",
    "summary": "Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently offered insights on. Cramer highlighted the company’s acquisition of Exact Sciences and said that it complements Abbott’s diagnostic business, as he remarked: “This morning, Abbott Labs announced that it’s buying Exact Sciences, that’s the colorectal cancer screening company, for about $21 billion. It’s a […]",
    "url": "https://finnhub.io/api/news?id=6990503d1c292c58a08ed83b4a895a1a7a214edeecf9ac8ed4bc9446157e9200",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763927496,
      "headline": "Jim Cramer on Abbott: “I Think It’s a Terrific Time to Do Some Buying”",
      "id": 137586801,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently offered insights on. Cramer highlighted the company’s acquisition of Exact Sciences and said that it complements Abbott’s diagnostic business, as he remarked: “This morning, Abbott Labs announced that it’s buying Exact Sciences, that’s the colorectal cancer screening company, for about $21 billion. It’s a […]",
      "url": "https://finnhub.io/api/news?id=6990503d1c292c58a08ed83b4a895a1a7a214edeecf9ac8ed4bc9446157e9200"
    }
  },
  {
    "ts": null,
    "headline": "Abbott’s (ABT) Exact Sciences Deal is “Very, Very Important,” Says Jim Cramer",
    "summary": "We recently published 10 Stocks Jim Cramer Talked About. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer discussed. This show marked more than a month after Cramer discussed pharmaceuticals and diagnostics devices firm Abbott Laboratories (NYSE:ABT). However, the delay doesn’t mean he’s changed his sentiment about the firm. Cramer often calls Abbott Laboratories […]",
    "url": "https://finnhub.io/api/news?id=80010f9a3dba6770cff3f8d5838ec6f5ea6da06faf0cb2ae17139919bc298b70",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763877312,
      "headline": "Abbott’s (ABT) Exact Sciences Deal is “Very, Very Important,” Says Jim Cramer",
      "id": 137586802,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "We recently published 10 Stocks Jim Cramer Talked About. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer discussed. This show marked more than a month after Cramer discussed pharmaceuticals and diagnostics devices firm Abbott Laboratories (NYSE:ABT). However, the delay doesn’t mean he’s changed his sentiment about the firm. Cramer often calls Abbott Laboratories […]",
      "url": "https://finnhub.io/api/news?id=80010f9a3dba6770cff3f8d5838ec6f5ea6da06faf0cb2ae17139919bc298b70"
    }
  }
]